Basics |
Company: |
Insulet Corporation |
IPO Date: |
May 15, 2007 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$19.84B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.64 | 1.91%
|
Avg Daily Range (30 D): |
$2.88 | 1.05%
|
Avg Daily Range (90 D): |
$2.88 | 1.10%
|
Institutional Daily Volume |
Avg Daily Volume: |
.45M |
Avg Daily Volume (30 D): |
.44M |
Avg Daily Volume (90 D): |
.42M |
Trade Size |
Avg Trade Size (Sh.): |
73 |
Avg Trade Size (Sh.) (30 D): |
31 |
Avg Trade Size (Sh.) (90 D): |
31 |
Institutional Trades |
Total Inst.Trades: |
9,529 |
Avg Inst. Trade: |
$5.29M |
Avg Inst. Trade (30 D): |
$15.03M |
Avg Inst. Trade (90 D): |
$14.59M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$9.02M |
Avg Closing Trade (30 D): |
$22.6M |
Avg Closing Trade (90 D): |
$22.5M |
Avg Closing Volume: |
53.17K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$6.02
|
$1.11
|
$2.69
|
Diluted EPS
|
$5.87
|
$1.08
|
$2.59
|
Revenue
|
$ 1.98B
|
$ 543.9M
|
$ 488.5M
|
Gross Profit
|
$ 1.38B
|
$ 377.1M
|
$ 330.9M
|
Net Income / Loss
|
$ 420.9M
|
$ 77.5M
|
$ 188.6M
|
Operating Income / Loss
|
$ 306M
|
$ 88.1M
|
$ 54.6M
|
Cost of Revenue
|
$ 607.9M
|
$ 166.8M
|
$ 157.6M
|
Net Cash Flow
|
$ 217.2M
|
$ 81.6M
|
$ 69.8M
|
PE Ratio
|
48.18
|
|
|
|